Reply to 'Cardiac remodeling after reduction of high-flow arteriovenous fistulas in end-stage renal disease: methodological issues'
Hypertens Res
.
2017 Apr;40(4):411.
doi: 10.1038/hr.2016.160.
Epub 2016 Dec 1.
Authors
Peter Wohlfahrt
1
2
3
,
Slavomir Rokosny
4
,
Vojtech Melenovsky
2
,
Barry A Borlaug
5
,
Vera Pecenkova
2
,
Peter Balaz
4
6
7
Affiliations
1
Center for Cardiovascular Prevention of the First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
2
Department of Cardiology, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
3
International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
4
Vascular and Transplant Surgery Department, Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic.
5
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
6
Department of Transplantation Renal Unit, Guy's Hospital, London, UK.
7
Department of Surgery, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic.
PMID:
27904157
DOI:
10.1038/hr.2016.160
No abstract available
Publication types
Comment
MeSH terms
Arteriovenous Fistula*
Heart
Humans
Kidney Failure, Chronic*
Renal Dialysis